Epilepsy is a chronic neurological disorder characterized by recurrent seizures. As a prevalent condition affecting over 65 million individuals worldwide, its effective management is a crucial area of interest for healthcare professionals. This article aims to provide an updated overview of the recent advancements in epilepsy management.
Several new antiepileptic drugs (AEDs) have been introduced, offering improved safety profiles and fewer drug interactions. These include Lacosamide, Rufinamide, and Eslicarbazepine. Moreover, Cannabidiol has emerged as a promising adjunctive treatment, particularly for drug-resistant seizures in Lennox-Gastaut syndrome and Dravet syndrome.
Surgical treatments for epilepsy have also seen significant advancements. Minimally invasive techniques such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided radiofrequency thermocoagulation have shown promising results. These procedures offer the potential for fewer complications and faster recovery times compared to traditional resective surgeries.
Neuromodulation therapies, including Vagus Nerve Stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS), have been refined and are increasingly being used as adjunctive treatments for drug-resistant epilepsy. These therapies offer a potential therapeutic option for patients who are not candidates for epilepsy surgery.
With the advent of next-generation sequencing technologies, genetic testing has become more accessible and affordable. This has enabled the identification of specific genetic mutations associated with various forms of epilepsy, paving the way for precision medicine in epilepsy management.
In conclusion, the field of epilepsy management has seen significant advancements in recent years. These have resulted in a broader range of treatment options, offering improved efficacy and safety for patients. Healthcare professionals should stay abreast of these advancements to provide the best possible care for their patients with epilepsy.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation